Organism 62365 - Streptomyces longisporeoflavus (STREPTOMYCETACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.

Organism Details

Property	Value
Family	STREPTOMYCETACEAE
Genus	STREPTOMYCES
Species	LONGISPOREOFLAVUS
Species authority
Subspecies	STRAIN R-19
Subspecies authority
Comment
Citation	CAI,Y: FREDENHAGEN,A: HUG,P: PETER,HH:. (1996). THE STAUROSPORINE PRODUCING STRAIN STREPTOMYCES LONGISPOROFLAVUS PRODUCES METABOLITES RELATED TO K-252A. PROPOSAL FOR BIOSYNTHETIC INTERMEDIATES OF K-252A.. 49(10)

Experiments

13 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
202089	ISOLATION AND IDENTIFICATION OF		Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	NOCARDIOPSIS ANTIBIOTIC K-252-A
202090	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN KINASE C INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	NOCARDIOPSIS ANTIBIOTIC K-252-A
202091	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	NOCARDIOPSIS ANTIBIOTIC K-252-A
202092	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHORYLASE KINASE INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	NOCARDIOPSIS ANTIBIOTIC K-252-A
202093	ISOLATION AND IDENTIFICATION OF		Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	NOCARDIOPSIS ANTIBIOTIC K-252-C
202094	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	STAUROSPORINE,N-METHYL:
202095	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN KINASE C INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	STAUROSPORINE,N-METHYL:
202096	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	STAUROSPORINE,N-METHYL:
202097	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHORYLASE KINASE INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	STAUROSPORINE,N-METHYL:
202098	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	STREPTOMYCES ANTIBIOTIC K-252-A,N-METHYL-3'-AMINO-3'-DEOXY:
202099	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEIN KINASE C INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	STREPTOMYCES ANTIBIOTIC K-252-A,N-METHYL-3'-AMINO-3'-DEOXY:
202100	PHARMACOLOGY OF COMPOUND - IN VITRO	CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	STREPTOMYCES ANTIBIOTIC K-252-A,N-METHYL-3'-AMINO-3'-DEOXY:
202101	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHORYLASE KINASE INHIBITION	Streptomyces longisporeoflavus (STREPTOMYCETACEAE)	STREPTOMYCES ANTIBIOTIC K-252-A,N-METHYL-3'-AMINO-3'-DEOXY:

Show SPARQL Queries (1)